Tri Chemical Laboratories Inc. (TYO:4369)
Japan · Delayed Price · Currency is JPY 3,065.00
+101.00 (3.41%)
Sep 4, 2026, 3:30 PM JST
Tri Chemical Laboratories Income Statement
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
| 26,214 | 23,883 | 18,905 | 11,246 | 13,803 | 11,574 | |
Revenue Growth | 12.48% | 26.33% | 68.10% | -18.52% | 19.26% | 18.09% |
Cost of Revenue | 16,583 | 14,864 | 10,894 | 7,160 | 8,224 | 6,740 |
Gross Profit | 9,631 | 9,019 | 8,011 | 4,086 | 5,579 | 4,834 |
Selling, General & Admin | 3,068 | 2,430 | 2,031 | 1,410 | 1,439 | 1,305 |
Research & Development | - | 606 | 660 | 665 | 569 | 486 |
Operating Expenses | 3,068 | 3,116 | 2,755 | 2,138 | 2,074 | 1,858 |
Operating Income | 6,563 | 5,903 | 5,256 | 1,948 | 3,505 | 2,976 |
Interest Expense | -71.26 | -34 | -23 | -23 | -28 | -31 |
Interest & Investment Income | 12.86 | 12 | 2 | 1 | - | - |
Earnings From Equity Investments | 1,307 | 1,277 | 1,309 | 1,036 | 2,409 | 1,936 |
Currency Exchange Gain (Loss) | - | - | - | 330 | - | 300 |
Other Non Operating Income (Expenses) | 4.86 | -69 | 38 | 8 | 300 | 129 |
EBT Excluding Unusual Items | 7,816 | 7,089 | 6,582 | 3,300 | 6,186 | 5,310 |
Gain (Loss) on Sale of Assets | - | - | - | -24 | - | -16 |
Pretax Income | 7,816 | 7,089 | 6,582 | 3,276 | 6,186 | 5,294 |
Income Tax Expense | 1,704 | 1,574 | 1,621 | 806 | 1,354 | 1,199 |
Net Income | 6,112 | 5,515 | 4,961 | 2,470 | 4,832 | 4,095 |
Net Income to Common | 6,112 | 5,515 | 4,961 | 2,470 | 4,832 | 4,095 |
Net Income Growth | 7.11% | 11.17% | 100.85% | -48.88% | 18.00% | 21.26% |
Shares Outstanding (Basic) | 32 | 32 | 32 | 32 | 32 | 32 |
Shares Outstanding (Diluted) | 32 | 32 | 32 | 32 | 32 | 32 |
Shares Change | - | - | - | - | 0.25% | 3.74% |
EPS (Basic) | 188.08 | 169.71 | 152.66 | 76.01 | 148.69 | 126.33 |
EPS (Diluted) | 188.08 | 169.71 | 152.66 | 76.01 | 148.69 | 126.33 |
EPS Growth | 7.11% | 11.17% | 100.85% | -48.88% | 17.70% | 16.89% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Free Cash Flow | 197.73 | -2,491 | 606 | 1,233 | 4,862 | 2,757 |
Free Cash Flow Per Share | 6.08 | -76.65 | 18.65 | 37.94 | 149.61 | 85.05 |
Dividend Per Share | 35.000 | 35.000 | 35.000 | 30.000 | 30.000 | 20.000 |
Dividend Growth | 0% | 0% | 16.67% | 0% | 50.00% | 17.65% |
Gross Margin | 36.74% | 37.76% | 42.38% | 36.33% | 40.42% | 41.77% |
Operating Margin | 25.04% | 24.72% | 27.80% | 17.32% | 25.39% | 25.71% |
Profit Margin | 23.32% | 23.09% | 26.24% | 21.96% | 35.01% | 35.38% |
Free Cash Flow Margin | 0.75% | -10.43% | 3.21% | 10.96% | 35.22% | 23.82% |
EBITDA | 8,837 | 7,820 | 6,628 | 3,252 | 4,714 | 3,995 |
EBITDA Margin | 33.71% | 32.74% | 35.06% | 28.92% | 34.15% | 34.52% |
D&A For EBITDA | 2,275 | 1,917 | 1,372 | 1,304 | 1,209 | 1,019 |
EBIT | 6,563 | 5,903 | 5,256 | 1,948 | 3,505 | 2,976 |
EBIT Margin | 25.04% | 24.72% | 27.80% | 17.32% | 25.39% | 25.71% |
Effective Tax Rate | 21.80% | 22.20% | 24.63% | 24.60% | 21.89% | 22.65% |